Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Diclofenac Sodium Delayed-release Tablets, USP 40-9184 Revised – June 2012
Medication labelWhy this: Advisory · dailymed-prescription
Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets, USP and other treatment options before deciding to use diclofenac sodium delayed-release. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). Diclofenac sodium delayed-release tablets are indicated: • For relief of the signs and symptoms of osteoarthritis • For relief of the signs and symptoms of rheumatoid arthritis • For acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis
- generic_name
- diclofenac sodium
- product_names
- Diclofenac Sodium
- ndc
- 66336-238, 0228-2550, 66336-238-20, 66336-238-30, 66336-238-60, 66336-238-90
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en